United States Ophthalmic Devices Market Outlook to 2033 - Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others

Description

List of Tables

GlobalData's "United States Ophthalmic Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Ophthalmic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories - Ophthalmic Viscoelastic Devices (OVD), Intraocular Lens (IOL), Glaucoma Surgery Devices, Ophthalmic Lasers and Corneal Implants

The United States Ophthalmic Devices Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Ophthalmic Devices Market.
Global corporate-level profiles of key companies operating within the United States Ophthalmic Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Ophthalmic Devices is segmented as follows -

Ophthalmic Viscoelastic Devices (OVD)
Intraocular Lens (IOL)
Glaucoma Surgery Devices
Ophthalmic Lasers
Corneal Implants

Reasons to Buy

The United States Ophthalmic Devices Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME0716MDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Ophthalmic Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Ophthalmic Devices Market, United States

3.1 Ophthalmic Devices Market, United States, Revenue ($m), 2018-2033
3.2 Ophthalmic Devices Market, United States, Revenue Mix ($m), 2023
3.3 Ophthalmic Devices Market, United States, Category Contribution by Revenue ($m), 2023
3.4 Ophthalmic Devices Market, United States, Revenue ($m), 2018-2033
3.5 Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
3.6 Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
3.7 Ophthalmic Devices Market, United States, Company Share by Revenue ($m), 2023

4 Corneal Implants Market, United States

4.1 Corneal Implants Market, United States, Revenue Mix ($m), 2023
4.2 Corneal Implants Market, United States, Segment Contribution (%), 2023
4.1 Corneal Implants Market, United States, Revenue ($m), 2018-2033
4.2 Corneal Implants Market, United States, Volume (Units), 2018-2033
4.3 Corneal Implants Market, United States, Average Price ($), 2018-2033
4.4 Corneal Implants Market, United States, Distribution Share by Revenue ($m), 2023
4.5 Corneal Implants Market, United States, Company Share by Revenue ($m), 2023

5 Glaucoma Surgery Devices Market, United States

5.1 Glaucoma Surgery Devices Market, United States, Revenue Mix ($m), 2023
5.2 Glaucoma Surgery Devices Market, United States, Segment Contribution (%), 2023
5.3 Glaucoma Surgery Devices Market, United States, Revenue ($m), 2018-2033
- 5.3.1 Glaucoma Drainage Devices Market, United States, Revenue ($m), by Segment, 2018-2033
5.4 Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
- 5.4.1 Glaucoma Drainage Devices Market, United States, Volume (Units), by Segment, 2018-2033
5.5 Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033
5.6 Glaucoma Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2023
5.7 Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2023

6 Intraocular Lens (IOL) Market, United States

6.1 Intraocular Lens (IOL) Market, United States, Revenue Mix ($m), 2023
6.2 Intraocular Lens (IOL) Market, United States, Segment Contribution (%), 2023
6.3 Intraocular Lens (IOL) Market, United States, Revenue ($m), 2018-2033
- 6.3.1 Foldable IOL Market, United States, Revenue ($m), by Segment, 2018-2033
6.4 Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
- 6.4.1 Foldable IOL Market, United States, Volume (Units), by Segment, 2018-2033
6.5 Intraocular Lens (IOL) Market, United States, Average Price ($) , 2018-2033
6.6 Intraocular Lens (IOL) Market, United States, Distribution Share by Revenue ($m), 2023
6.7 Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), 2023

7 Ophthalmic Lasers Market, United States

7.1 Ophthalmic Lasers Market, United States, Revenue Mix ($m), 2023
7.2 Ophthalmic Lasers Market, United States, Segment Contribution (%), 2023
7.3 Ophthalmic Lasers Market, United States, Revenue ($m), 2018-2033
7.4 Ophthalmic Lasers Market, United States, Volume (Units), 2018-2033
7.5 Ophthalmic Lasers Market, United States, Average Price ($), 2018-2033
7.6 Ophthalmic Lasers Market, United States, Distribution Share by Revenue ($m), 2023
7.7 Ophthalmic Lasers Market, United States, Company Share by Revenue ($m), 2023

8 Ophthalmic Viscoelastic Devices (OVD) Market, United States

8.1 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue Mix ($m), 2023
8.2 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Segment Contribution (%), 2023
8.3 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), 2018-2033
8.4 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), 2018-2033
8.5 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Average Price ($) , 2018-2033
8.6 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Distribution Share by Revenue ($m), 2023
8.7 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Company Share by Revenue ($m), 2023

9 Overview of Key Companies in United States, Ophthalmic Devices Market

9.1 Alcon Inc
- 9.1.1 Company Overview
9.2 Johnson & Johnson Vision Care Inc
- 9.2.1 Company Overview
9.3 Bausch & Lomb Inc
- 9.3.1 Company Overview
9.4 Glaukos Corp
- 9.4.1 Company Overview
9.5 SightLife
- 9.5.1 Company Overview
9.6 Allergan Aesthetics
- 9.6.1 Company Overview
9.7 Carl Zeiss Meditec AG
- 9.7.1 Company Overview
9.8 Meridian Ag
- 9.8.1 Company Overview
9.9 CorneaGen Inc
- 9.9.1 Company Overview
9.10 New World Medical, Incorporated
- 9.10.1 Company Overview

10 Ophthalmic Devices Market Pipeline Products

11 Financial Deals Landscape

11.1 Acquisition
- 11.1.1 Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
- 11.1.2 Sonendo to Acquire Biolase for USD14 Million
- 11.1.3 Sanner Acquires Gilero
- 11.1.4 CYIOS Acquires Noir Medical Supplies
- 11.1.5 Advancing Eyecare Holdings Acquires Eyefficient
- 11.1.6 Bausch + Lomb Acquires Trukera Medical from Accelmed Partners
- 11.1.7 DuPont de Nemours Acquires Donatelle Plastics
- 11.1.8 Sightpath Medical Acquires PennVista
- 11.1.9 Nordson Acquires Atrion For USD800 Million
- 11.1.10 Specac Acquires Harrick Scientific
- 11.1.11 Chadwick Optical Acquires Aire-O-Lite Optical
11.2 Debt Offerings
- 11.2.1 Iridex to Raise USD4.2 Million in Private Placement of Senior Convertible Promissory Notes
- 11.2.2 Vitazi.AI Raises USD0.66 Million in Debt Offering
- 11.2.3 OPKO Health to Raise USD250 Million in Public Offering of 7.5% Notes Due 2044
- 11.2.4 Clearflow (Clear Cathetar Systems) Raises USD2.32 Million in Debt Offering
- 11.2.5 Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
- 11.2.6 Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
- 11.2.7 JelliSee Ophthalmics Raises Additional USD2.05 Million in Debt Financing
- 11.2.8 Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of 4.874% Notes Due 2029

12 Recent Developments

12.1 Corporate Communications
- 12.1.1 Dec 03, 2024: Exergen Unveils Improved Award-Winning TemporalScanner TAT-2000C for At-home Use in US and Canada
- 12.1.2 Dec 03, 2024: Canon Medical Informatics Selected by Major Non-profit Health System to Standardize Advanced Visualization across 25+ Locations
- 12.1.3 Sep 23, 2024: OPKO Health's ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer
- 12.1.4 Sep 10, 2024: Marshall B. Ketchum University Names Greta Vines-Douglas as Director of School of Physician Assistant Studies
- 12.1.5 Sep 09, 2024: Stryker Spine Receives Additional FDA 510(k) Clearance for Vitoss BiModal Bioactive Bone Graft Substitute Foam Strip
- 12.1.6 Sep 09, 2024: Boston Scientific Receives Additional 510(K) Clearance For Epic Biliary Endoscopic Stent System
- 12.1.7 Sep 03, 2024: Samsara Vision Promotes Jason Herod to Chief Commercial Officer
- 12.1.8 Jul 18, 2024: Eyenuk Appoints Bryan Haardt as Chief Executive Officer
- 12.1.9 Jul 01, 2024: AMETEK Names Keith Kowalski as Vice President and General Manager, AMS Division
- 12.1.10 Jun 14, 2024: Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
- 12.1.11 Jun 05, 2024: VSP Vision Hires Usha Patil as Chief Insurance Officer
- 12.1.12 May 31, 2024: Children's Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition
- 12.1.13 May 09, 2024: AMETEK Appoints Patrick L. Williams Vice President and General Manager, Maintenance, Repair, Overhaul (MRO) Division
- 12.1.14 May 07, 2024: Oculis Publishes Invitation to the Annual General Meeting
- 12.1.15 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA)
- 12.1.16 Mar 28, 2024: Mojo Vision Hires Achin Bhowmik to Board of Directors
- 12.1.17 Mar 25, 2024: Stony Brook Professor George Leibowitz Assumes Role from Interim Dean Richard L. Edwards
12.2 Financial Announcements
- 12.2.1 Jan 07, 2025: Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study
- 12.2.2 Dec 05, 2024: CooperCompanies Releases Q4 and Full Year 2024 Financial Results
- 12.2.3 Dec 04, 2024: Foshan SOCO Precision Instrument Receives 510(K) Clearance ForHigh-Speed Air Turbine Handpiece Model - SCHF22
- 12.2.4 Dec 04, 2024: Hangzhou Clongene Biotech Receives CLIA Approval For CLUNGENE Fentanyl Home Test Cassette
- 12.2.5 Dec 03, 2024: ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
- 12.2.6 Dec 03, 2024: Reveal Genomics and IEO initiate breast cancer test impact study
- 12.2.7 Dec 02, 2024: Sernova Update on Strategic Initiatives
- 12.2.8 Dec 02, 2024: Ascelia Pharma Presents Orviglance Sparkle Study Primary Results as Cutting-Edge Research at the 2024 RSNA Annual Meeting
- 12.2.9 Oct 31, 2024: Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024
- 12.2.10 Oct 30, 2024: STAAR Surgical Announces Q3 2024 Results
- 12.2.11 Oct 23, 2024: STAAR Surgical to Report Third Quarter Results on October 30, 2024
- 12.2.12 Oct 17, 2024: Anika Announces Third Quarter 2024 Results Conference Call Date
- 12.2.13 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
- 12.2.14 Oct 09, 2024: Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
- 12.2.15 Oct 03, 2024: Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
- 12.2.16 Sep 26, 2024: Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024
- 12.2.17 Aug 27, 2024: Oculis Announces Results for Quarter Ended June 30, 2024
- 12.2.18 Aug 13, 2024: Syntec Optics to Host Conference Call to Discuss Financial Results and Business Update
- 12.2.19 Aug 08, 2024: Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
- 12.2.20 Aug 02, 2024: Interface Announces Q2 2024 Results
- 12.2.21 Aug 01, 2024: NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
- 12.2.22 Aug 01, 2024: LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- 12.2.23 Aug 01, 2024: Regeneron Reports Second Quarter 2024 Financial and Operating Results
- 12.2.24 Jul 30, 2024: Corning Reports Strong Second-Quarter 2024 Financial Results, Exceeding April Guidance and Marking Return to Year-over-Year Sales Growth
- 12.2.25 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
- 12.2.26 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings
- 12.2.27 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-ST-C Dental Zirconia Block
- 12.2.28 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-3D-Pro ML Dental Zirconia Block
- 12.2.29 Jun 21, 2024: NX Development Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan
- 12.2.30 Jun 17, 2024: OMNIVISION Announces Smallest Camera Module for 3D Intraoral Dental Scanners
- 12.2.31 May 14, 2024: Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th
- 12.2.32 May 09, 2024: Warby Parker Announces First Quarter 2024 Results
- 12.2.33 May 06, 2024: Microline Surgical Receives An Additional 510(k) Clearance For ReNew XR Handpiece
- 12.2.34 May 06, 2024: Huizhou Foryou Medical Devices Receives An Additional 510(k) Clearance For LUOFUCON Collagen Wound Dressing
- 12.2.35 May 06, 2024: UG GLOBAL RESOURCES SDN BHD Receives 510(K) Clearance For

Black Pearl Nitrile Examination Glove

12.2.36 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA)
12.2.37 May 06, 2024: Regeneron Announces Investor Conference Presentations
12.2.38 May 02, 2024: Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy
12.2.39 Apr 26, 2024: Gentex Reports First Quarter 2024 Financial Results
12.2.40 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
12.2.41 Apr 04, 2024: BD to Announce Financial Results for its Second Quarter of Fiscal 2024
12.2.42 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
12.2.43 Feb 27, 2024: Interface Announces Q4 and Full Year 2023 Results
12.2.44 Jan 30, 2024: Corning Reports Fourth-Quarter and Full-Year 2023 Financial Results
12.2.45 Jan 26, 2024: Gentex Reports Fourth Quarter and Year End 2023 Financial Results
12.2.46 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

12.3 Government and Public Interest
- 12.3.1 Nov 14, 2024: Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs
- 12.3.2 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024
- 12.3.3 Mar 11, 2024: Solco Biomedical Receives Additional 510(K) Clearance For 4CIS VERTU Spine System
- 12.3.4 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences
- 12.3.5 Feb 15, 2024: BD to Present at Investor Healthcare Conferences
- 12.3.6 Feb 05, 2024: FibroGen to Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024
- 12.3.7 Jan 22, 2024: Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
12.4 Legal And Regulatory
- 12.4.1 Dec 18, 2024: Moberg Pharma Announces New terbinafine Supplier Secured
- 12.4.2 Sep 09, 2024: Insulet Receives Additional FDA 510(k) Clearance for Omnipod 5 POD Delivery System
- 12.4.3 Sep 09, 2024: Boston Scientific Receives Additional 510(K) Clearance For Rhythmia HDx Mapping System
- 12.4.4 Sep 06, 2024: Fujifilm Healthcare Europe Announces ARIETTA 750 FF ENDO Compatibility with Fujifilm Ultrasound Endoscopes and Endobronchial Ultrasound Scope
- 12.4.5 Jul 01, 2024: CDRH Announces Expansion of the Total Product Life Cycle Advisory Program
12.5 Other Significant Developments
- 12.5.1 Oct 29, 2024: Solutionreach Introduces Secure Documents Tool to Aid Optometry Practices with FTC Eyeglass Rule Compliance
- 12.5.2 Oct 11, 2024: Non-invasive eye test for multiple diseases to advance under $4.8M NIH award
- 12.5.3 Oct 08, 2024: VisionVentions Launches to Revolutionize Ophthalmic Device Innovation with Advanced Additive Manufacturing
- 12.5.4 Sep 12, 2024: MellingMedical Signs NX Contracts to Source Topcon Devices
- 12.5.5 Sep 11, 2024: ID Mystyle 3 and ID Workstyle 3 to Share Hoya's Best Technology Platform Lead by Adaptease Technology
- 12.5.6 Aug 28, 2024: JEDMED Joins MellingMedical's Lineup of Medical Products Providers
- 12.5.7 Jul 30, 2024: Corning Reports Strong Second-Quarter 2024 Financial Results, Exceeding April Guidance and Marking Return to Year-over-Year Sales Growth
- 12.5.8 May 02, 2024: Ocutrx Technologies Sets New Standards in Augmented and Mixed Reality with Over 25 Groundbreaking Patents for Transformative Healthcare and More
- 12.5.9 Apr 12, 2024: Syntec Optics Secures Order to Develop New Disposable Optics for Digital Health Treatment
- 12.5.10 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
- 12.5.11 Feb 21, 2024: AmoyDx PD-L1 (E1L3N) assay gained the priority recommendation from Chinese expert consensus
- 12.5.12 Feb 05, 2024: Corning's New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines
12.6 Product News
- 12.6.1 Nov 20, 2024: Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT
- 12.6.2 Nov 07, 2024: Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
- 12.6.3 Oct 16, 2024: Elysium Health Announces the Launch of Vision for Eye Longevity, Performance, and Protection
- 12.6.4 Oct 15, 2024: Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
- 12.6.5 Oct 07, 2024: NTC Launches Imperial, the New Eye Drops Product Line on the Patient's Side
- 12.6.6 Oct 01, 2024: ASU Researchers Use AI to Help People See More Clearly
- 12.6.7 Sep 12, 2024: OCuSOFT and Dr. Paul Karpecki Set the Record Straight on Retaine MGD
- 12.6.8 Aug 27, 2024: Bruder Healthcare Introduces Eyeleve MGD, A Trusted Eye Drop Formula Under A New Brand
- 12.6.9 Aug 17, 2024: Pulse Biosciences Receives Additional FDA 510(k) Clearance for CellFX Percutaneous Electrode System
- 12.6.10 Aug 13, 2024: New UH Study Targets Early Signs of Vision Loss in Diabetic Patients
- 12.6.11 Aug 01, 2024: New Zeiss Study Finds Majority of Parents Worry about Impact of Screen Time on Their Children's Eye Health, Value Protective Behaviors to Maintain Eyesight
- 12.6.12 Jul 29, 2024: UW Model Shows Cortical Implants Like Elon Musk's Blindsight Unlikely to 'Exceed Normal Human Vision'
- 12.6.13 Jul 23, 2024: Mann Eye Institute Introduces Cutting-Edge miCOR Technology for Advanced Cataract Surgery
- 12.6.14 Jul 15, 2024: Eye Injection Kit Recall: Bausch + Lomb/Synergetics Removes Certain I-Pack Injection Kits Due to Potential Non-Sterility
- 12.6.15 Jul 08, 2024: Emory University Announces AI Technology Advances Early Detection of Severe Eye Inflammation, New Research Shows
- 12.6.16 Jun 10, 2024: Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
- 12.6.17 Jun 03, 2024: BioTissue Introduces CAM360 AmnioGraft, Redefining Regenerative Therapy for Dry Eye and Other Ocular Surface Disorders
- 12.6.18 May 28, 2024: Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting
- 12.6.19 Apr 30, 2024: Heidelberg Engineering Showcases the Future of Imaging, Extending Its Capabilities with a Breadth of Research Technology
- 12.6.20 Apr 29, 2024: Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
- 12.6.21 Apr 25, 2024: Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension
- 12.6.22 Apr 15, 2024: ForSight Robotics Completes Robotic Cataract Surgery Using ORYOM Platform
- 12.6.23 Apr 12, 2024: Syntec Optics Secures Order to Develop New Disposable Optics for Digital Health Treatment
- 12.6.24 Apr 10, 2024: AI Makes Retinal Imaging 100 Times Faster, Compared to Manual Method
- 12.6.25 Apr 09, 2024: Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024
- 12.6.26 Apr 04, 2024: WCG Launches Total Feasibility for Faster, More Efficient Study Planning & Site Selection
- 12.6.27 Apr 04, 2024: Verana Health Developing Qdata Dry Eye Disease, the Largest Real-World Dataset of its Kind
- 12.6.28 Apr 03, 2024: Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings
- 12.6.29 Feb 22, 2024: RetinalGeniX Technologies Granted a Patent for System And Method For Visualization Of Ocular Anatomy
- 12.6.30 Feb 05, 2024: Electronic Adhesives by Meridian EPO-TEK Highlighted at MD&M West
12.7 Strategy And Business Planning
- 12.7.1 Dec 03, 2024: Aavantgarde Announces Oral Presentation of Luce-1 Clinical Study at Floretina 2024 Annual Meeting
- 12.7.2 Nov 07, 2024: Harrow Announces Nationwide Launch of New Digital Patient Access Solution in Collaboration With Asembia
- 12.7.3 May 30, 2024: Corning Launches New Digital and IT Center in Pune, India
- 12.7.4 Apr 25, 2024: Polyu Forms Global Partnership with Zeiss Vision Care to Expand Impact and Accelerate Market Penetration of Patented Myopia Control Technology
- 12.7.5 Apr 24, 2024: Athenahealth and the American Council of the Blind Collaborate to Expand Digital Accessibility for Athenahealth Patients
- 12.7.6 Mar 22, 2024: Guangzhou Xinbo Electronic Received Additional FDA 510(K) Clearance For Pain Therapy Device

13 Appendix

13.1 Research Methodology
- 13.1.1 Coverage
- 13.1.2 Secondary Research
- 13.1.3 Primary Research
- 13.1.4 Market Modeling and Forecasting
- 13.1.5 Company Share Analysis
- 13.1.6 Distribution Share Analysis
- 13.1.7 Benchmarking
13.2 GlobalData Consulting
13.3 Contact Us
13.4 Disclaimer

Product Code: GDME0716MDB

List of Table

List of Tables

Table 1: Ophthalmic Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Ophthalmic Devices Market, United States, Category Contribution by Revenue ($m), 2023
Table 3: Ophthalmic Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
Table 5: Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
Table 6: Ophthalmic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 7: Corneal Implants Market, United States, Segment Contribution (%), 2023
Table 8: Corneal Implants Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 9: Corneal Implants Market, United States, Volume (Units), 2018-2033
Table 10: Corneal Implants Market, United States, Average Price ($), 2018-2033
Table 11: Corneal Implants Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 12: Corneal Implants Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 13: Glaucoma Surgery Devices Market, United States, Segment Contribution (%), 2023
Table 14: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 15: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 16: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
Table 17: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033
Table 18: Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033
Table 19: Glaucoma Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 20: Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 21: Intraocular Lens (IOL) Market, United States, Segment Contribution (%), 2023
Table 22: Intraocular Lens (IOL) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 23: Foldable IOL Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 24: Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
Table 25: Foldable IOL Market, United States, Volume (Units), 2018-2033
Table 26: Intraocular Lens (IOL) Market, United States, Average Price ($), 2018-2033
Table 27: Intraocular Lens (IOL) Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 28: Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 29: Ophthalmic Lasers Market, United States, Segment Contribution (%), 2023
Table 30: Ophthalmic Lasers Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 31: Ophthalmic Lasers Market, United States, Volume (Units), 2018-2033
Table 32: Ophthalmic Lasers Market, United States, Average Price ($), 2018-2033
Table 33: Ophthalmic Lasers Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 34: Ophthalmic Lasers Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 35: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Segment Contribution (%), 2023
Table 36: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 37: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), 2018-2033
Table 38: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Average Price ($), 2018-2033
Table 39: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 40: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 41: Ophthalmic Devices Market Pipeline Products
Table 42: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
Table 43: Sonendo to Acquire Biolase for USD14 Million
Table 44: Sanner Acquires Gilero
Table 45: CYIOS Acquires Noir Medical Supplies
Table 46: Advancing Eyecare Holdings Acquires Eyefficient
Table 47: Bausch + Lomb Acquires Trukera Medical from Accelmed Partners
Table 48: DuPont de Nemours Acquires Donatelle Plastics
Table 49: Sightpath Medical Acquires PennVista
Table 50: Nordson Acquires Atrion For USD800 Million
Table 51: Specac Acquires Harrick Scientific
Table 52: Chadwick Optical Acquires Aire-O-Lite Optical
Table 53: Iridex to Raise USD4.2 Million in Private Placement of Senior Convertible Promissory Notes
Table 54: Vitazi.AI Raises USD0.66 Million in Debt Offering
Table 55: OPKO Health to Raise USD250 Million in Public Offering of 7.5% Notes Due 2044
Table 56: Clearflow (Clear Cathetar Systems) Raises USD2.32 Million in Debt Offering
Table 57: Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
Table 58: Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
Table 59: JelliSee Ophthalmics Raises Additional USD2.05 Million in Debt Financing
Table 60: Becton, Dickinson and Company (Becton Dickinson and Co) Raises USD625 Million in Public Offering of 4.874% Notes Due 2029
Table 61: Total Number of Primary Research Participants, Ophthalmic Devices Market, by Country

List of Figure

List of Figures

Figure 1: Ophthalmic Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Ophthalmic Devices Market, United States, Revenue Mix ($m), 2023
Figure 3: Ophthalmic Devices Market, United States, Category Contribution (%), 2023
Figure 4: Ophthalmic Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
Figure 6: Ophthalmic Devices Market, United States, Volume (Units), 2018-2033
Figure 7: Ophthalmic Devices Market, United States, Company Share (%) 2023
Figure 8: Corneal Implants Market, United States, Revenue Mix ($m), 2023
Figure 9: Corneal Implants Market, United States, Segment Contribution (%), 2023
Figure 10: Corneal Implants Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 11: Corneal Implants Market, United States, Volume (Units), 2018-2033
Figure 12: Corneal Implants Market, United States, Company Share (%) 2023
Figure 13: Glaucoma Surgery Devices Market, United States, Revenue Mix ($m), 2023
Figure 14: Glaucoma Surgery Devices Market, United States, Segment Contribution (%), 2023
Figure 15: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 16: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 17: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
Figure 18: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033
Figure 19: Glaucoma Surgery Devices Market, United States, Company Share (%) 2023
Figure 20: Intraocular Lens (IOL) Market, United States, Revenue Mix ($m), 2023
Figure 21: Intraocular Lens (IOL) Market, United States, Segment Contribution (%), 2023
Figure 22: Intraocular Lens (IOL) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 23: Foldable IOL Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 24: Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
Figure 25: Foldable IOL Market, United States, Volume (Units), 2018-2033
Figure 26: Intraocular Lens (IOL) Market, United States, Company Share (%) 2023
Figure 27: Ophthalmic Lasers Market, United States, Revenue Mix ($m), 2023
Figure 28: Ophthalmic Lasers Market, United States, Segment Contribution (%), 2023
Figure 29: Ophthalmic Lasers Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 30: Ophthalmic Lasers Market, United States, Volume (Units), 2018-2033
Figure 31: Ophthalmic Lasers Market, United States, Company Share (%) 2023
Figure 32: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue Mix ($m), 2023
Figure 33: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Segment Contribution (%), 2023
Figure 34: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 35: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), 2018-2033
Figure 36: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Company Share (%) 2023